View Older Stories View More Recent Stories

Oct 31, 2019 08:00AM Daré Bioscience Announces Presentation of Two Posters at American Association of Pharmaceutical Scientists 2019 PharmSci 360
Oct 31, 2019 08:00AM Daré Bioscience Announces Presentation of Two Posters at American Association of Pharmaceutical Scientists 2019 PharmSci 360
Oct 28, 2019 08:00AM Daré Bioscience and Strategic Science & Technologies Announce Presentation of Positive Findings from Thermography Clinical Study of Sildenafil Cream, 3.6 % in Healthy Women at the Sexual Medicine Soc
Oct 28, 2019 08:00AM Daré Bioscience and Strategic Science & Technologies Announce Presentation of Positive Findings from Thermography Clinical Study of Sildenafil Cream, 3.6 % in Healthy Women at the Sexual Medicine
Oct 10, 2019 08:01AM Dare Bioscience (DARE) Announces Poster Presentation on Pharmacokinetic Study of DARE-FRT1, in Development for Sustained-Release Progesterone Therapy for Pregnancy Maintenance
Oct 10, 2019 08:00AM Daré Bioscience Announces a Poster Presentation on a Pharmacokinetic Study of DARE-FRT1, in Development for Sustained-Release Progesterone Therapy for Pregnancy Maintenance, at the American Society f
Oct 10, 2019 08:00AM Daré Bioscience Announces a Poster Presentation on a Pharmacokinetic Study of DARE-FRT1, in Development for Sustained-Release Progesterone Therapy for Pregnancy Maintenance, at the American Society f
Oct 7, 2019 08:00AM Daré Bioscience to Present an Overview on its Intravaginal Ring (IVR) Technology in Development for Sustained-Release Hormone Therapy and Pregnancy Maintenance at the 9th Annual Partnership Opportuni
Oct 7, 2019 08:00AM Daré Bioscience to Present an Overview on its Intravaginal Ring (IVR) Technology in Development for Sustained-Release Hormone Therapy and Pregnancy Maintenance at the 9th Annual Partnership Opportuni
Sep 4, 2019 08:00AM Daré Bioscience to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Sep 4, 2019 08:00AM Daré Bioscience to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Aug 14, 2019 04:01PM Daré Bioscience Reports Second Quarter 2019 Financial Results and Company Update
Aug 14, 2019 04:01PM Daré Bioscience Reports Second Quarter 2019 Financial Results and Company Update
Aug 6, 2019 08:00AM Daré Bioscience to Host Second Quarter 2019 Financial Results and Company Update Conference Call and Webcast
Aug 6, 2019 08:00AM Daré Bioscience to Host Second Quarter 2019 Financial Results and Company Update Conference Call and Webcast
Jun 26, 2019 08:10AM Dare Bioscience (DARE) Reports Complete Recruitment in Pre-Pivotal Trial of Ovaprene
Jun 26, 2019 08:00AM Daré Bioscience Completes Recruitment in Pre-Pivotal Trial Of Monthly Woman-Controlled, Hormone-Free Contraceptive Candidate, Ovaprene®
Jun 26, 2019 08:00AM Daré Bioscience Completes Recruitment in Pre-Pivotal Trial Of Monthly Woman-Controlled, Hormone-Free Contraceptive Candidate, Ovaprene®
Jun 17, 2019 08:08AM Dare Bioscience (DARE) Announces Positive Results in Thermography Feasibility Study with Sildenafil Cream
Jun 17, 2019 08:00AM Daré Bioscience, Inc. Announces Positive Results in Thermography Feasibility Study with Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
Jun 17, 2019 08:00AM Daré Bioscience, Inc. Announces Positive Results in Thermography Feasibility Study with Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
May 29, 2019 08:00AM Daré Bioscience to Present at the 2019 BIO International Convention
May 29, 2019 08:00AM Daré Bioscience to Present at the 2019 BIO International Convention
May 14, 2019 04:00PM Daré Bioscience Reports First Quarter 2019 Financial Results and Company Update
May 14, 2019 04:00PM Daré Bioscience Reports First Quarter 2019 Financial Results and Company Update
May 8, 2019 08:00AM Daré Bioscience Announces the Publication of a Pharmacokinetics Study of DARE-FRT1, a Potential Therapy for Preterm Birth and Fertility, in Drug Delivery and Translational Research
May 7, 2019 08:00AM Daré Bioscience to Host First Quarter 2019 Financial Results and Company Update Conference Call and Webcast
May 7, 2019 08:00AM Daré Bioscience to Host First Quarter 2019 Financial Results and Company Update Conference Call and Webcast
Apr 15, 2019 08:00AM Dr. James Simon, Award-Winning Physician, Presents on Ovaprene® as a Promising Novel Non-Hormonal Contraceptive Method in Clinical Development
Apr 15, 2019 08:00AM Dr. James Simon, Award-Winning Physician, Presents on Ovaprene® as a Promising Novel Non-Hormonal Contraceptive Method in Clinical Development
Apr 8, 2019 08:00AM Daré Bioscience Announces Publication of Pharmacokinetics Study of DARE-HRT1, a Potential Hormone Replacement Therapy, in the Journal of Pharmaceutical Sciences
Apr 8, 2019 08:00AM Daré Bioscience Announces Publication of Pharmacokinetics Study of DARE-HRT1, a Potential Hormone Replacement Therapy, in the Journal of Pharmaceutical Sciences
Apr 1, 2019 04:32PM Dare Bioscience (DARE) Regains Listing Compliance on Nasdaq
Apr 1, 2019 04:30PM Daré Bioscience, Inc. Regains Listing Compliance on Nasdaq
Apr 1, 2019 04:30PM Daré Bioscience, Inc. Regains Listing Compliance on Nasdaq
Apr 1, 2019 08:00AM Daré Bioscience, Inc. to Host Business Update and Full Year 2018 Financial Results Conference Call and Webcast
Apr 1, 2019 08:00AM Daré Bioscience, Inc. to Host Business Update and Full Year 2018 Financial Results Conference Call and Webcast
Mar 29, 2019 08:00AM World-renowned Scientist, Described as the Edison of Medicine by Forbes Magazine, Dr. Robert Langer Joins Daré Bioscience Scientific Advisory Board
Mar 29, 2019 08:00AM World-renowned Scientist, Described as the Edison of Medicine by Forbes Magazine, Dr. Robert Langer Joins Daré Bioscience Scientific Advisory Board
Jan 10, 2018 09:01AM Sabrina Martucci Johnson Joins Aethlon Medical's Board of Directors
View More Recent Stories View Older Stories